Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
7.18
-0.26 (-3.49%)
Apr 29, 2026, 12:11 PM EDT - Market open
Fulcrum Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 50.26 | 197.53 | 58.21 | 25.56 | 35.1 | 35.41 | Upgrade
|
| Short-Term Investments | 283.06 | 154.77 | 182.81 | 210.66 | 167.82 | 182.75 | Upgrade
|
| Cash & Short-Term Investments | 333.32 | 352.31 | 241.02 | 236.22 | 202.92 | 218.16 | Upgrade
|
| Cash Growth | 47.09% | 46.17% | 2.03% | 16.41% | -6.99% | 93.21% | Upgrade
|
| Accounts Receivable | - | - | 2.1 | 0.54 | 0.23 | 3.64 | Upgrade
|
| Other Receivables | 1.78 | 1.07 | 1.25 | 1.71 | 0.85 | 0.47 | Upgrade
|
| Receivables | 1.78 | 1.07 | 3.34 | 2.25 | 1.08 | 4.11 | Upgrade
|
| Prepaid Expenses | 3.58 | 4.1 | 5.56 | 3.73 | 3.52 | 3.73 | Upgrade
|
| Total Current Assets | 338.67 | 357.48 | 249.92 | 242.2 | 207.52 | 226 | Upgrade
|
| Property, Plant & Equipment | 6.35 | 7.07 | 9.58 | 12.39 | 15.97 | 7.37 | Upgrade
|
| Other Long-Term Assets | 1.75 | 1.74 | 1.21 | 3.1 | 3.2 | 1.63 | Upgrade
|
| Total Assets | 346.77 | 366.28 | 260.72 | 257.69 | 226.69 | 235 | Upgrade
|
| Accounts Payable | 2.45 | 1.59 | 1.16 | 2.76 | 3.64 | 4.79 | Upgrade
|
| Accrued Expenses | 4.65 | 8.79 | 7.23 | 8.33 | 9.45 | 9.16 | Upgrade
|
| Current Portion of Leases | 2.46 | 2.4 | 2.19 | 2.19 | 2.6 | - | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 0.93 | 4.71 | Upgrade
|
| Other Current Liabilities | 0.31 | 0.26 | 0.46 | 0.4 | 0.11 | 0.54 | Upgrade
|
| Total Current Liabilities | 9.86 | 13.05 | 11.04 | 13.68 | 16.73 | 19.2 | Upgrade
|
| Long-Term Leases | 3.41 | 4.04 | 6.44 | 8.63 | 10.82 | - | Upgrade
|
| Other Long-Term Liabilities | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 4.26 | Upgrade
|
| Total Liabilities | 13.47 | 17.28 | 17.68 | 22.5 | 27.74 | 23.46 | Upgrade
|
| Common Stock | 0.07 | 0.07 | 0.05 | 0.06 | 0.05 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 946.92 | 943.04 | 762.25 | 744.94 | 612.03 | 514.36 | Upgrade
|
| Retained Earnings | -613.17 | -594.28 | -519.4 | -509.67 | -412.34 | -302.47 | Upgrade
|
| Comprehensive Income & Other | -0.51 | 0.17 | 0.13 | -0.14 | -0.8 | -0.4 | Upgrade
|
| Total Common Equity | 333.3 | 349 | 243.03 | 235.19 | 198.94 | 211.54 | Upgrade
|
| Shareholders' Equity | 333.3 | 349 | 243.03 | 235.19 | 198.94 | 211.54 | Upgrade
|
| Total Liabilities & Equity | 346.77 | 366.28 | 260.72 | 257.69 | 226.69 | 235 | Upgrade
|
| Total Debt | 5.87 | 6.44 | 8.63 | 10.82 | 13.42 | - | Upgrade
|
| Net Cash (Debt) | 327.45 | 345.86 | 232.39 | 225.4 | 189.5 | 218.16 | Upgrade
|
| Net Cash Growth | 49.86% | 48.83% | 3.10% | 18.95% | -13.14% | 93.24% | Upgrade
|
| Net Cash Per Share | 4.90 | 5.46 | 3.75 | 3.68 | 4.21 | 6.17 | Upgrade
|
| Filing Date Shares Outstanding | 66.63 | 66.6 | 53.98 | 61.94 | 61.76 | 40.63 | Upgrade
|
| Total Common Shares Outstanding | 66.61 | 66.58 | 53.97 | 61.92 | 52.1 | 40.63 | Upgrade
|
| Working Capital | 328.81 | 344.43 | 238.88 | 228.52 | 190.79 | 206.8 | Upgrade
|
| Book Value Per Share | 5.00 | 5.24 | 4.50 | 3.80 | 3.82 | 5.21 | Upgrade
|
| Tangible Book Value | 333.3 | 349 | 243.03 | 235.19 | 198.94 | 211.54 | Upgrade
|
| Tangible Book Value Per Share | 5.00 | 5.24 | 4.50 | 3.80 | 3.82 | 5.21 | Upgrade
|
| Machinery | 11.16 | 11.15 | 10.84 | 10.68 | 10.24 | 9.15 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.03 | - | Upgrade
|
| Leasehold Improvements | 6.36 | 7.12 | 7.12 | 7.1 | 7.1 | 6.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.